ARTICLE
28 January 2025

Holland & Knight Health Dose: January 21, 2025

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Hearings
  • Senate Report Releases Private Equity Investment in Healthcare
  • MedPAC Recommends Congress Increase Physician Payment, Cut Nursing Home Payments
  • FTC Releases Second Report on PBM Practices
  • DEA Telemedicine Prescribing Rules
  • 2026 Medicare Advantage and Part D Advance Notice
  • Notice of Benefit and Payment Parameters for 2026
  • FDA
  • CMS
  • First Day EOs
  • U.S. Supreme Court to Hear Arguments that Challenge ACA Constitutionality

Read the full Health Dose ยป

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More